CCXI Chemocentryx Inc

ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

$51.67  +0.01 (0.01%)
As of 09/30/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/08/2012
Outstanding shares:  71,355,872
Average volume:  1,516,890
Market cap:   $3,686,244,348
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B6ZL968
Valuation   (See tab for details)
PE ratio:   -26.21
PB ratio:   14.20
PS ratio:   134.24
Return on equity:   -54.36%
Net income %:   -512.21%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy